Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBMP-2/CPM for Proximal Femur Fractures
NCT00384358Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
Phase 2, randomised, single-blind trial of dibotermin alfa in proximal femur fracture (PFF) (3 arms), sponsored by Pfizer. Primary endpoint: Incidence of secondary fracture displacement at 6 months. Started Dec 2006; status: completed.
02
Drugs
dibotermin alfa
03
Conditions
proximal femur fracture (PFF)
Beyond the preview
Go deeper on NCT00384358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384358.